መነሻ › አኩት ማይሎይድ ሊውኬሚያ › North Carolina › Durham
በDurham፣ NC ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ 33 ጥናቶች በDurham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Durham VA Medical Center, Durham
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University Medical Center, Durham
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 ማይል ርቀት
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
ተሳታዮችን በመፈለግ ላይደረጃ 3
- US-Chapel Hill-UNCNORTHCAROLINA, Chapel Hill · 10 ማይል ርቀት
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 ማይል ርቀት
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Durham
- Research Site, Chapel Hill · 10 ማይል ርቀት
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
ተሳታዮችን በመፈለግ ላይ
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
Registry of Older Patients With Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
A Study of Revumenib and Mezigdomide in People With Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 ማይል ርቀት
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Duke University, Durham
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 ማይል ርቀት
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke Blood Cancer Center, Durham
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke Cancer Center, Durham
Novel Digital Application for Patients With Acute Leukemia
ተሳታዮችን በመፈለግ ላይ
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University Medical Center, Durham
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Duke University, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
በሌሎች ከተሞች ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ጥናቶች
- Houston, TX85 ጥናቶች
- New York City, NY51 ጥናቶች
- Boston, MA44 ጥናቶች
- Seattle, WA41 ጥናቶች
- Baldwin Park, CA40 ጥናቶች
- Columbus, OH35 ጥናቶች
- Philadelphia, PA34 ጥናቶች
- Atlanta, GA31 ጥናቶች
- Tampa, FL29 ጥናቶች
- Chicago, IL26 ጥናቶች
- Portland, OR25 ጥናቶች
- Washington, DC24 ጥናቶች
በDurham ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር64 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)58 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር39 ጥናቶች
- Multiple Myeloma37 ጥናቶች
- Metastatic Cancer33 ጥናቶች
- የፕሮስቴት ካንሰር32 ጥናቶች
- የሳንባ ካንሰር32 ጥናቶች
- የኮሎሬክታል ካንሰር28 ጥናቶች
- የእንቁላል ካንሰር27 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ27 ጥናቶች
- የልብ ድካም26 ጥናቶች
- የፓንክሪያስ ካንሰር24 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።